天津龙济男人(天津省天津龙济是正规的吗) (今日更新中)

The severe water shortages have become a major bottleneck to our sustainable development. Nearly two-thirds of the cities in China lack water," said Chen Lei, Minister of Water Resources.From 2011 to 2015, China will strive to limit its annual water consumption within 620 billion cubic meters and cut water consumption per 10,000 yuan of GDP by 30 percent.

BEIJING, Jan. 24 (Xinhua) -- China's top economic planner said Monday that price supervision and control measures have achieved steady progress with 2010's Consumer Price Index, slightly exceeding the target ceiling by 0.3 percentage points to hit 3.3 percent.To rein in soaring commodities prices, joint efforts have been made to manage inflation expectations, promote production, ensure supplies and strengthen price supervision in 2010, said the National Development and Reform Commission (NDRC) in an online statement.Prices of necessities accelerating during the second half of 2010 have been contained with vegetable prices down 9.4 percent in December from the previous month last year, it said.Further, prices of edible vegetable, pork, egg, sugar,liquefied petroleum gas and clothing also decreased significantly in December month on month, the statement said.To cope with rising prices beginning in July 2010, especially prices of basic supplies, the central government promptly introduced joint inter-ministerial meetings to discuss price controls among 17 ministries and ordered local governments to establish the same mechanism, it noted.Local governments have worked on improving agricultural facilities, especially in south China's Hainan province, to increase vegetables supplies for northern cities over the past year, the statement said.The statement forecasts that vegetable planting areas in 2010's autumn and winter will increase 530,000 hectares year on year, sending output to 337 million tonnes.To ensure production and supply, departments have worked to reduce fertilizer exports and promote links between production areas and purchasing areas, it added.Further, relevant authorities also took measures to stabilize prices of electricity and coal, and to ensure smooth transportation of agricultural produce.Authorities also granted temporary subsidies and raised basic wages and minimum living subsidies for urban and rural residents to guarantee people's daily life.

WASHINGTON, May 20 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Sutent to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body.Neuroendocrine tumors found in the pancreas are slow-growing and rare. It is estimated that there are fewer than 1,000 new cases in the United States each year.This is the second new approval by the FDA to treat patients with this disease. On May 5, the agency approved Afinitor."FDA believes it is important to provide cancer patients with as many treatment options as possible," said Richard Pazdur, director of the Office of Oncology Drug Products in the FDA's Center for Drug Evaluation and Research. "The agency is committed to working with companies to bring innovative new therapies to the market and encourages companies to continue exploring additional uses for approved products."The safety and effectiveness of Sutent was established in a single study of 171 patients with metastatic (late-stage) or locally advanced (disease that could not be removed with surgery) disease who received Sutent or a placebo (sugar pill). The study was designed to measure the length of time a patient lived before their disease spread or worsened (progression-free survival).Results from the study demonstrate that Sutent provided benefit to patients by prolonging the median length of time they lived without the cancer spreading or worsening to 10.2 months compared to 5.4 months for patients who received placebo.In patients treated with Sutent for neuroendocrine pancreatic tumors, the most commonly reported side effects included diarrhea, nausea, vomiting, fatigue, anorexia, high blood pressure, energy loss, stomach pain, changes in hair color, inflammation of the mouth, and a decrease in infection-fighting white blood cells.Sutent is marketed by New York City-based Pfizer.

BEIJING, Feb.14 (Xinhua) - Shanghai General Motors Co. will recall 2,806 imported Cadillac CTS vehicles in China to repair faulty track bars to prevent safety risks, China's quality watchdog said on Monday.The recall, which is set to begin on March 21, includes models that were produced between June 16, 2008 and April 20, 2009, the General Administration of Quality Supervision, Inspection and Quarantine said in a statement on its website.The statement said that the company would repair or replace the rear suspension track bars of the recalled vehicles because some nuts on the bars are likely to loosen and cause worn screw threads.This could lead to a loosened track bar under extreme conditions, which is unsafe when traveling fast, it said.The company is to contact car owners to provide free checks and repairs. Owners may also contact the automaker on its free phone service (telephone number: 8008201902) for more information and to make appointments.

WASHINGTON, May 11 (Xinhua) -- NASA's Dawn spacecraft has obtained its first image of the giant asteroid Vesta, which will help fine-tune navigation during its approach, the U.S. space agency announced Wednesday.Dawn expects to achieve orbit around Vesta on July 16, when the asteroid is about 117 million miles from Earth.The image from Dawn's framing cameras was taken on May 3 when the spacecraft began its approach and was approximately 752,000 miles (1.21 million km) from Vesta. The asteroid appears as a small, bright pearl against a background of stars. Vesta also is known as a protoplanet, because it is a large body that almost formed into a planet."After plying the seas of space for more than a billion miles, the Dawn team finally spotted its target," said Carol Raymond, Dawn's deputy principal investigator at NASA's Jet Propulsion Laboratory in Pasadena, California. "This first image hints of detailed portraits to come from Dawn's upcoming visit."Vesta is 330 miles (530 km) in diameter and the second most massive object in the asteroid belt. Ground- and space-based telescopes obtained images of the bright orb for about two centuries, but with little surface detail.Mission managers expect Vesta's gravity to capture Dawn in orbit on July 16. To enter orbit, Dawn must match the asteroid's path around the sun, which requires very precise knowledge of the body's location and speed. By analyzing where Vesta appears relative to stars in framing camera images, navigators will pin down its location and enable engineers to refine the spacecraft's trajectory.Dawn will start collecting science data in early August at an altitude of approximately 1,700 miles (2,700 km) above the asteroid's surface. As the spacecraft gets closer, it will snap multi-angle images allowing scientists to produce topographic maps. Dawn will later orbit at approximately 120 miles (200 km) to perform other measurements and obtain closer shots of parts of the surface. Dawn will remain in orbit around Vesta for one year. After another long cruise phase, Dawn will arrive in 2015 at its second destination, Ceres, an even more massive body in the asteroid belt.Gathering information about these two icons of the asteroid belt will help scientists unlock the secrets of our solar system's early history. The mission will compare and contrast the two giant asteroids shaped by different forces. Dawn's science instruments will measure surface composition, topography and texture. Dawn also will measure the tug of gravity from Vesta and Ceres to learn more about their internal structures. The spacecraft's full odyssey will take it on a 3-billion-mile (5-billion-km) journey, which began with its launch in September 2007.

来源：资阳报